Effects of erythropoietin on electrocardiogram changes in carbon monoxide poisoning: An experimental study in rats

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 4, 2012, Pages 1191-1199

  Rezaee, Mitra Asgharian ^a   Moallem, Seyed Adel ^a,b,d   Imenshahidi, Mohsen ^a   Farzadnia, Mahdi ^c   Mohammadpour, Amir Hooshang ^a,d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbon monoxide poisoning; Cardiotoxicity; Electrocardiogram; Erythropoietin

Indexed keywords

CARBOXYHEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; RHEPO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARBON MONOXIDE BLOOD LEVEL; CARBON MONOXIDE INTOXICATION; CARDIOTOXICITY; CONTROLLED STUDY; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; Q WAVE; RAT; REOXYGENATION; SPECTROPHOTOMETRY; ST SEGMENT ELEVATION; T WAVE INVERSION;

EID: 84871351951     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prockop LD and Chichkova RI. Carbon monoxide intoxication: an updated review. J. Neurol. Sci. (2007) 262: 122-130.
2. Goldstein M. Carbon monoxide poisoning. J. Emerg. Nurs. (2008) 34: 538-542.
3. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y and Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J. Am. Coll. Cardiol. (2005) 45: 1513-1516.
4. Ernst A and Zibrak JD. Carbon monoxide poisoning. N. Engl. J. Med. (1998) 339: 1603-1608.
5. Kao LW and Nanagas KA. Toxicity associated with carbon monoxide. Clin. Lab. Med. (2006) 26: 99-125.
6. Weaver LK. Clinical practice. Carbon monoxide poisoning. N. Engl. J. Med. (2009) 360: 1217-1225.
7. Katzman GM and Penney DG. Electrocardiographic responses to carbon monoxide and cyanide in the conscious rat. Toxicol. Lett. (1993) 69: 139-153.
8. Fineschi V, Agricola E, Baroldi G, Bruni G, Cerretani D and Mondillo S. Myocardial fndings in fatal carbon monoxide poisoning: a human and experimental morphometric study. Int. J. Legal Med. (2000) 113: 276-282.
9. Lipsic E, Schoemaker RG, van der Meer P, Voors AA, van Veldhuisen DJ and van Gilst WH. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J. Am. Coll. Cardiol. (2006) 48: 2161-2167.
10. Paschos N, Lykissas MG and Beris AE. The role of erythropoietin as an inhibitor of tissue ischemia. Int. J. Biol. Sci. (2008) 4: 161-168.
11. Erik Li, Regien GS, Peter van der M, Adriaan AV, Dirk JVV and Wiek HVG. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J. Am. Coll. Cardiol. (2006) 48: 2161-2167.
12. van der Meer P, Voors AA, Lipsic E, van Gilst WH and van Veldhuisen DJ. Erythropoietin in cardiovascular diseases. Eur. Heart J. (2004) 25: 285-291.
13. Joyeux-Faure M, Godin-Ribuot D and Ribuot C. Erythropoietin and myocardial protection: what〉s new? Fundam. Clin. Pharmacol. (2005) 19: 439-446.
14. Flecknell P. Laboratory Animal Anaesthesia. Academic Press.
15. Hara S, Mukai T, Kurosaki K, Mizukami H, Kuriiwa F and Endo T. Role of nitric oxide system in hydroxyl radical generation in rat striatum due to carbon monoxide poisoning, as determined by microdialysis. Toxicology (2007) 239: 136-143.
16. Iheagwara KN, Thom SR, Deutschman CS and Levy RJ. Myocardial cytochrome oxidase activity is decreased following carbon monoxide exposure. Biochim. Biophys. Acta (2007) 1772: 1112-1116.
17. Favory R, Lancel S, Tissier S, Mathieu D, Decoster B and Neviere R. Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation. Am. J. Respir. Crit. Care Med. (2006) 174: 320-325.
18. Rodkey FL, Hill TA, Pitts LL and Robertson RF. Spectrophotometric measurement of carboxyhemoglobin and methemoglobin in blood. Clin. Chem. (1979) 25: 1388-1393.
19. Herring N and Paterson DJ. ECG diagnosis of acute ischaemia and infarction: past, present and future. QJM (2006) 99: 219-230.
20. Kao LW and Nanagas KA. Carbon monoxide poisoning. Emerg. Med. Clin. North Am. (2004) 22: 985-1018.
21. Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc. Res. (2004) 63: 208-216.
22. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes benefcial remodeling. Proceed. National Acad. Sci. USA (2003) 100: 4802-4806.
23. Lipsic E, van der Meer P, Henning RH, Suurmeijer AJ, Boddeus KM, van Veldhuisen DJ. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J. Cardiovasc. Pharmacol. (2004) 44: 473-479.
24. Bullard AJ, Govewalla P and Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in-vitro and in-vivo. Basic Res. Cardiol. (2005) 100: 397-403.
25. Chattopadhyay A, Das Choudhury T, Bandyopadhyay D and Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem. Pharmacol. (2000) 59: 419-425.